Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 631-637

  Browner, Warren S ^a,b,c   Lui, Li Yung ^a,b   Cummings, Steven R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c California Pacific Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; OSTEOPROTEGERIN;

AGED; AGING; ARTICLE; BONE DENSITY; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BONE DENSITY; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRACTURES, BONE; GLYCOPROTEINS; HUMANS; MORTALITY; OBSERVER VARIATION; ODDS RATIO; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SAN FRANCISCO; SMOKING;

EID: 0035094860     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.631     Document Type: Article

References (32)

1. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
2. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
3. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
4. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteodastogenesis-inhibitory factor and is identical to TRANCE/RANKL
5. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
6. Recent advances in bone biology provide insight into the pathogenesis of bone diseases
7. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
8. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
9. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
10. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
11. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis
12. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
13. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
14. Axial and appendicular bone density predict fractures in older women
15. The mystery of diabetes and atherosclerosis: Time for a new plot
16. Diabetes and cardiovascular disease. The "common soil" hypothesis
17. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice
18. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calfication by blocking a process resembling osteoclastogenesis
19. Atherosclerosis in amputated legs of patients with and without diabetes mellitus
20. Medial artery calcification. A neglected harbinger of cardiovascular complications in noninsulin-dependent diabetes mellitus
21. The role of osteoprogenitors in vascular calcification
22. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease
23. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets
24. Increasing serum osteocalcin after glycemic control in diabetic men
25. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
26. Molecular determinants of arterial calcification
27. Osteopontin expression in cardiovascular diseases
28. Atherosclerotic calcification: Relation to developmental osteogenesis
29. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin
30. Ectopic calcification: Gathering hard facts about soft tissue mineralization
31. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients
32. The atherosclerosis-calcification link?